JNJoseph H. Nadeau

Joseph H. Nadeau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joseph H. Nadeau has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • David A. Buchner

    Department of Biochemistry Case Western Reserve University School of Medicine Cleveland Ohio USA

    3 shared publications
  • Shankar Subramaniam

    Department of Bioengineering, University of California, San Diego, CA, USA

    3 shared publications
  • Soha N. Yazbek

    Department of Genetics , Case Western Reserve University School of Medicine , Cleveland, OH 44106 , USA

    2 shared publications
  • Alistair G. Rust

    European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK

    1 shared publication
  • Annie E. Hill

    Department of Genetics, Case Western Reserve University School of Medicine, Cleveland, Ohio

    1 shared publication
  • Annie E. Hill-Baskin

    Department of Genetics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA

    1 shared publication

Latest Publications

  • Open Access

    Pathways, networks, and systems medicine—the meeting place of the Aegean and the mind

    by Shankar Subramaniam, Joseph H. Nadeau

  • Open Access

    Systems physiology—the heart of the matter or a bone of contention?

    by Shankar Subramaniam, Joseph H. Nadeau

  • Open Access

    Ancestral paternal genotype controls body weight and food intake for multiple generations

    by Soha N. Yazbek, Sabrina H. Spiezio, Joseph H. Nadeau, David A. Buchner

    Current treatments have largely failed to slow the rapidly increasing world-wide prevalence of obesity and its co-morbidities. Despite a strong genetic contribution to obesity (40–70%), only a small percentage of heritability is explained with current knowledge of monogenic abnormalities, common sequence variants and conventional modes of inheritance. Epigenetic effects are rarely tested in humans because of difficulties arranging studies that distinguish conventional and transgenerational inheritance while simultaneously controlling environmental factors and learned behaviors. However, growing evidence from model organisms implicates genetic and environmental factors in one generation that affect phenotypes in subsequent generations. In this report, we provide the first evidence for paternal transgenerational genetic effects on body weight and food intake. This test focused on the obesity-resistant 6C2d congenic strain, which carries the Obrq2aA/J allele on an otherwise C57BL/6J background. Various crosses between 6C2d and the control C57BL/6J strain showed that the Obrq2aA/J allele in the paternal or grandpaternal generation was sufficient to inhibit diet-induced obesity and reduce food intake in the normally obesity-susceptible, high food intake C57BL/6J strain. These obesity-resistant and reduced food intake phenotypes were transmitted through the paternal lineage but not the maternal lineage with equal strength for at least two generations. Eliminating social interaction between the father and both his offspring and the pregnant dam did not significantly affect food intake levels, demonstrating that the phenotype is transmitted through the male germline rather than through social interactions. Persistence of these phenotypes across multiple generations raises the possibility that transgenerational genetic effects contribute to current metabolic conditions.


  • Top Cited Papers

    Missing heritability and strategies for finding the underlying causes of complex disease

    by Evan E. Eichler, Jonathan Flint, Greg Gibson, Augustine Kong, Suzanne M. Leal, Jason H. Moore, Joseph H. Nadeau

    Seven leading geneticists express their views about where the unidentified components of the heritability for complex human diseases might lie and how this could affect the underlying genetic architecture, as well as offering suggestions of how genomic research could be targeted to address this key issue. Although recent genome-wide studies have provided valuable insights into the genetic basis of human disease, they have explained relatively little of the heritability of most complex traits, and the variants identified through these studies have small effect sizes. This has led to the important and hotly debated issue of where the 'missing heritability' of complex diseases might be found. Here, seven leading geneticists offer their opinion about where this heritability is likely to lie, what this could tell us about the underlying genetic architecture of common diseases and how this could inform research strategies for uncovering genetic risk factors.


  • Open Access

    Deep short-read sequencing of chromosome 17 from the mouse strains A/J and CAST/Ei identifies significant germline variation and candidate genes that regulate liver triglyceride levels

    by Ian Sudbery, Jim Stalker, Jared T Simpson, Thomas Keane, Alistair G Rust, Matthew E Hurles, Klaudia Walter, Dee Lynch, Lydia Teboul, Steve D Brown, et al.

    Genome sequences are essential tools for comparative and mutational analyses. Here we present the short read sequence of mouse chromosome 17 from the Mus musculus domesticus derived strain A/J, and the Mus musculus castaneus derived strain CAST/Ei. We describe approaches for the accurate identification of nucleotide and structural variation in the genomes of vertebrate experimental organisms, and show how these techniques can be applied to help prioritize candidate genes within quantitative trait loci.


  • Open Access

    Diet-induced hepatocellular carcinoma in genetically predisposed mice

    by Annie E. Hill-Baskin, Maciej M. Markiewski, David A. Buchner, Haifeng Shao, David DeSantis, Gene Hsiao, Shankar Subramaniam, Nathan A. Berger, Colleen Croniger, John D. Lambris, et al.

    Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide, with ∼70% of cases resulting from hepatitis B and C viral infections, aflatoxin exposure, chronic alcohol use or genetic liver diseases. The remaining ∼30% of cases are associated with obesity, type 2 diabetes and related metabolic diseases, although a direct link between these pathologies and HCCs has not been established. We tested the long-term effects of high-fat and low-fat diets on males of two inbred strains of mice and discovered that C57BL/6J but not A/J males were susceptible to non-alcoholic steatohepatitis (NASH) and HCC on a high-fat but not low-fat diet. This strain–diet interaction represents an important model for genetically controlled, diet-induced HCC. Susceptible mice showed morphological characteristics of NASH (steatosis, hepatitis, fibrosis and cirrhosis), dysplasia and HCC. mRNA profiles of HCCs versus tumor-free liver showed involvement of two signaling networks, one centered on Myc and the other on NFκB, similar to signaling described for the two major classes of HCC in humans. miRNA profiles revealed dramatically increased expression of a cluster of miRNAs on the X chromosome without amplification of the chromosomal segment. A switch from high-fat to low-fat diet reversed these outcomes, with switched C57BL/6J males being lean rather than obese and without evidence for NASH or HCCs at the end of the study. A similar diet modification may have important implications for prevention of HCCs in humans.


  • Resistance to diet-induced obesity in mice with a single substituted chromosome

    by David A. Buchner, Lindsay C. Burrage, Annie E. Hill, Soha N. Yazbek, William E. O'BRien, Colleen M. Croniger, Joseph H. Nadeau

    Obesity and its comorbidities are taking an increasing toll on human health. Key pathways that were identified with single gene variants in humans and model organisms have led to improved understanding and treatment of rare cases of human obesity. However, similar progress remains elusive for the more common multifactorial cases of metabolic dysfunction and disease. A survey of mouse chromosome substitution strains (CSSs) provided insight into the complex genetic control of diet-induced obesity and related conditions. We now report a survey of 60 traits related to obesity and metabolic syndrome in mice with a single substituted chromosome as well as selected traits measured in congenic strains derived from the substituted strain. We found that each strain that was resistant to diet-induced obesity had a distinct phenotype that uniquely modeled different combinations of traits related to metabolic disease. For example, the chromosome 6 CSS remained insulin resistant in the absence of obesity, demonstrating an atypical relationship between body weight and insulin resistance. These results provide insights into the genetic control of constant components of this mouse model of diet-induced metabolic disease as well as phenotypes that vary depending on genetic background. A better understanding of these genotype-phenotype relationships may enable a more individualized diagnosis and treatment of obesity and the metabolic syndrome.